pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 789 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 1
MOMA-313
Metastatic Breast Cancer
Moma Therapeutics Inc
0 catalysts
Phase 1
MRT-6160
Axial Spondyloarthritis
$NVSNOVARTIS AG
0 catalysts
Phase 1
MRT-8102
Inflammation
$GLUEMonte Rosa Therapeutics, Inc.
0 catalysts
Phase 1
← prev
page 15 of 27
next →
131
Pain89
Neurology1
MRX-2843
Non-Small Cell Lung Cancer
Meryx Inc
0 catalysts
Phase 1
MRX-8
Acinetobacter Infections
MicuRx Pharmaceuticals Inc
0 catalysts
Phase 1
MT-101
Parkinson's Disease
MThera Pharma Co Ltd
0 catalysts
Phase 1
MTI-201
Metastatic Uveal Melanoma
Modulation Therapeutics Inc
0 catalysts
Phase 1
Medchew Dronabinol
dronabinol
Chemotherapy Induced Nausea and Vomiting
$IXHLIncannex Healthcare Inc.
0 catalysts
Phase 1
MuSK-CAART
Myasthenia Gravis
$CABACabaletta Bio, Inc.
0 catalysts
Phase 1
MyoPAXon
Duchenne Muscular Dystrophy
Myogenica Inc
0 catalysts
Phase 1
NA-731
Traumatic Brain Injury
Biomed Industries Inc
0 catalysts
Phase 1
NAS-150
Idiopathic Pulmonary Fibrosis
New Amsterdam Sciences Inc
0 catalysts
Phase 1
NC-2400
Dyslipidemia
ABIONYX Pharma SA
0 catalysts
Phase 1
NIM-1324
Rheumatoid Arthritis
NImmune Biopharma Inc
0 catalysts
Phase 1
NKT-3964
Adenocarcinoma Of The Gastroesophageal Junction
NiKang Therapeutics Inc
0 catalysts
Phase 1
NLX-101
Fragile X Syndrome
Neurolixis Inc
0 catalysts
Phase 1
NM-5072
Paroxysmal Nocturnal Hemoglobinuria
NovelMed Therapeutics Inc
0 catalysts
Phase 1
NM-6603
Colorectal Cancer
Nucmito
0 catalysts
Phase 1
NMS-812
Refractory Acute Myeloid Leukemia
Nerviano Medical Sciences SRL
0 catalysts
Phase 1
NN-3201
Adenoid Cystic Carcinoma (ACC)
Novelty Nobility Inc
0 catalysts
Phase 1
NNI-362
Alzheimer's Disease
NeuroNascent Inc
0 catalysts
Phase 1
NO-13065
Obesity
Otsuka Pharmaceutical Co Ltd
0 catalysts
Phase 1
NOVA-1010
Schizophrenia
Novastage Pharmaceuticals (Shenzhen) Ltd
0 catalysts
Phase 1
NP-10679
Subarachnoid Hemorrhage
NeurOp Inc
0 catalysts
Phase 1
NP-3
Nephropathic Cystinosis
Nacuity Pharmaceuticals Inc
0 catalysts
Phase 1
NPX-887
Adenocarcinoma Of The Gastroesophageal Junction
NextPoint Therapeutics Inc
0 catalysts
Phase 1
NRL-1049
Cavernous Hemangioma (Cerebral Cavernous Malformation/Cerebral Cavernous Hema…
Neurelis Inc
0 catalysts
Phase 1
NRS-033
Opium (Opioid) Addiction
Nirsum Laboratories Inc
0 catalysts
Phase 1
NTP-42
Pulmonary Arterial Hypertension
ATXA Therapeutics Ltd
0 catalysts
Phase 1
NTS-1104
Acute Ischemic Stroke
NeuroTrauma Sciences LLC
0 catalysts